![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 9
2017
Jäger, E.; Mehlis, K.; Mumm, F.; Laryionava, K.; Hiddemann, W.; Winkler, E. und Heussner, P.
(2017):
Patients' preferences concerning their information needs and their preferred role in participation in end-of-life decision-making (EPAL-Study).
In: Oncology Research and Treatment, Bd. 40: S. 281-282
2016
Mehlis, K.; Jaeger, E.; Laryionava, K.; Mumm, F.; Hiddemann, W.; Heussner, P. und Winkler, E. C.
(2016):
Importance of a good patient-communication in situations of treatment limitation - results from the EPAL-Study (Ethics Policy for Advanced Care Planning and Limiting Treatment).
In: Oncology Research and Treatment, Bd. 39: S. 302-303
Jaeger, E.; Mehlis, K.; Mumm, F.; Laryionava, K.; Hiddemann, W.; Winkler, E. C. und Heussner, P.
(2016):
Patients' preferences concerning quality and quantity of life. Results from the EPAL-Study (Ethics Policy for Advanced Care Planning and Limiting Treatment).
In: Oncology Research and Treatment, Bd. 39: S. 303
Mehlis, K.; Jaeger, E.; Laryionava, K.; Mumm, F.; Hiddemann, W.; Heussner, P. und Winkler, E. C.
(2016):
Patients' information needs and involvement in decisions to limit treatment in the EPAL-Study (Ethics policy for advanced care planning and limiting treatment).
In: Oncology Research and Treatment, Bd. 39: S. 303
Winkler, E.; Mehlis, K.; Jaeger, E.; Laryionava, K.; Hiddemann, W. und Heussner, P.
(2016):
The EPAL-project (Ethics policy for advanced care planning and limiting treatment).
In: Oncology Research and Treatment, Bd. 39: S. 33-34
Laryionava, K.; Mehlis, K.; Hiddemann, W.; Heußner, P. und Winkler, E. C.
(2016):
"Rather one more chemo than one less ..." Young adult's patients and chemotherapy in advanced cancer. A study of oncologists' views.
In: Oncology Research and Treatment, Bd. 39: S. 230
Jaeger, E.; Mehlis, K.; Mumm, F.; Laryionava, K.; Hiddemann, W.; Winkler, E. C. und Heußner, P.
(2016):
Development and Validity of a Checklist Assessing the Risk of Bias of Randomized Trials, Observational Studies and Systematic Reviews Analyzing Drug Adverse Events.
In: Oncology Research and Treatment, Bd. 39: S. 241
Jaeger, E.; Winkler, E.; Mehlis, K.; Mumm, F.; Laryionava, K.; Hiddemann, W. und Heußner, P.
(2016):
End-of-Life decision-making in patients with advanced cancer - an ethics policy for advanced care planning and limiting treatment (EPAL).
In: Oncology Research and Treatment, Bd. 39: S. 31-32
Mehlis, K.; Jaeger, E.; Mumm, F.; Laryionava, K.; Hiddemann, W.; Heußner, P. und Winkler, E. C.
(2016):
Patient information needs and treatment goals in the EPAL-Study (Ethics policy for advanced care planning and limiting treatment).
In: Oncology Research and Treatment, Bd. 39: S. 31